These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modulation of [3H]quinpirole binding at striatal D2 dopamine receptors by a monoamine oxidaseA-like site: evidence from radioligand binding studies and D2 receptor- and MAO(A)-deficient mice. Levant B, Morgan KA, Ahlgren-Beckendorf JA, Grandy DK, Chen K, Shih JC, Seif I. Life Sci; 2001 Nov 30; 70(2):229-41. PubMed ID: 11787947 [Abstract] [Full Text] [Related]
8. Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049. Culver KE, Szechtman H, Levant B. Eur J Pharmacol; 2008 Sep 11; 592(1-3):67-72. PubMed ID: 18644362 [Abstract] [Full Text] [Related]
9. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum. Paterson IA, Juorio AV, Berry MD, Zhu MY. J Pharmacol Exp Ther; 1991 Sep 11; 258(3):1019-26. PubMed ID: 1679846 [Abstract] [Full Text] [Related]
10. Differential pharmacological profile of striatal and cerebellar dopamine receptors labeled by [3H]quinpirole: identification of a discrete population of putative D3 receptors. Levant B, DeSouza EB. Synapse; 1993 May 11; 14(1):90-5. PubMed ID: 8099762 [Abstract] [Full Text] [Related]
11. Binding of sigma-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes. Itzhak Y, Stein I, Zhang SH, Kassim CO, Cristante D. J Pharmacol Exp Ther; 1991 Apr 11; 257(1):141-8. PubMed ID: 1850463 [Abstract] [Full Text] [Related]
12. Dopamine receptors labelled by [3H]quinpirole. Seeman P, Schaus JM. Eur J Pharmacol; 1991 Oct 02; 203(1):105-9. PubMed ID: 1686763 [Abstract] [Full Text] [Related]
13. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites. Itzhak Y, Mash D, Zhang SH, Stein I. Mol Pharmacol; 1991 Mar 02; 39(3):385-93. PubMed ID: 1848660 [Abstract] [Full Text] [Related]
15. A comparison of the binding of sigma opioids and phencyclidine, and the interaction with antipsychotic drugs in rat brain membranes. Downes CP, Lewis PE, Stone MA. Br J Pharmacol; 1986 May 02; 88(1):231-7. PubMed ID: 2871882 [Abstract] [Full Text] [Related]
16. Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. Tam SW, Cook L. Proc Natl Acad Sci U S A; 1984 Sep 02; 81(17):5618-21. PubMed ID: 6147851 [Abstract] [Full Text] [Related]
17. Novel drug interactions at D(2) dopamine receptors: modulation of [3H]quinpirole binding by monoamine oxidase inhibitors. Levant B. Life Sci; 2002 Oct 25; 71(23):2691-700. PubMed ID: 12383877 [Abstract] [Full Text] [Related]
18. Autoradiographic localization of [3H]quinpirole binding to dopamine D2 and D3 receptors in rat brain. Gehlert DR, Gackenheimer SL, Seeman P, Schaus J. Eur J Pharmacol; 1992 Feb 11; 211(2):189-94. PubMed ID: 1351846 [Abstract] [Full Text] [Related]
19. Modulation by estradiol and progesterone of the GTP effect on striatal D-2 dopamine receptors. Lévesque D, Di Paolo T. Biochem Pharmacol; 1993 Feb 09; 45(3):723-33. PubMed ID: 8095140 [Abstract] [Full Text] [Related]
20. Characterization of [3H]quinpirole binding to human dopamine D2A and D3 receptors: effects of ions and guanine nucleotides. Malmberg A, Mohell N. J Pharmacol Exp Ther; 1995 Aug 09; 274(2):790-7. PubMed ID: 7636742 [Abstract] [Full Text] [Related] Page: [Next] [New Search]